In the eyes of Tesla shareholders, Elon Musk hardly needed another distraction. OpenAI could turn out to be a costly one.

Stifel analyst Paul Matteis lowered the firm’s price target on Biogen (BIIB) to $144 from $175 and keeps a Hold rating on the shares. The ...

Stifel analysts took a cautious stance on IPG Photonics (NASDAQ:IPGP), revising the company's price target downward to $85 from the previous target of $100. Despite the reduction, Stifel continues to ...

MoneyLion operates a “content-as-a-service platform” called mFeed, and Stifel Discover is expected to deliver personalized ...

Stifel analysts adjusted their stance on Exelixis (NASDAQ:EXEL) shares, raising the price target to $36 from the previous $30, while keeping a Hold rating on the stock. The new price target reflects ...

We recently compiled a list of the 12 Best International Dividend Stocks To Buy Now. In this article, we are going to take a ...

Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...

We recently compiled a list of the 10 AI News Updates on Wall Street’s Radar. In this article, we are going to take a look at ...

After reaching a net worth of more than $486 billion in December, Elon Musk’s wealth has sunk below $400 billion for the ...

According to Benzinga Pro, Stifel Financial's peer group average for short interest as a percentage of float is 3.37%, which ...

Today’s Forbes Daily covers El Segundo’s defense tech movement, Trump’s funding violation, Eric Adams update, Elon Musk’s bid to buy OpenAI, Super Bowl ratings and more.

"Opinions on Elon Musk have taken a turn for the worse along political affiliations," Stifel analyst Stephen Gengaro said.